Procept Biorobotics Corp PRCT Stock Forecast
AI-powered price prediction and analysis for Procept Biorobotics Corp · Alpha · vs marketSwitch to Total
See PRCT's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Procept Biorobotics Corp
Procept Biorobotics Corp (PRCT) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.
Latest News
Where PRCT sits on the market map
Surgical & Medical Instruments & Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| PRCT Procept Biorobotics Corp | ▲ | $1.09B | – |
| SYK Stryker Corp | ▼ | $108.38B | 29.1x |
| MMM 3m Co | ▼ | $83.94B | 28.0x |
| BSX Boston Scientific Corp | ▼ | $62.77B | 17.1x |
| BDX Becton Dickinson & Co | ▼ | $51.04B | 54.2x |
| MDLN Medline Inc. | ▶ | $46.94B | – |
| RMD Resmed Inc | ▼ | $33.91B | 22.3x |
| DXCM Dexcom Inc | ▶ | $32.42B | 32.4x |
| WST West Pharmaceutical Services Inc | ▼ | $26.17B | 46.3x |
| SOLV Solventum Corp | ▼ | $14.69B | 10.2x |
| BAX Baxter International Inc | ▶ | $12.87B | – |
| PEN Penumbra Inc | ▼ | $12.61B | 78.5x |
| GMED Globus Medical Inc | ▼ | $10.25B | 19.1x |
| GKOS Glaukos Corp | ▲ | $9.76B | – |
| PODD Insulet Corp | ▼ | $9.58B | 25.5x |
| STVN Stevanato Group S.P.A. | ▲ | $5.83B | – |
| HAE Haemonetics Corp | ▼ | $5.54B | 57.5x |
| TFX Teleflex Inc | ▼ | $5.27B | – |
| MMSI Merit Medical Systems Inc | ▼ | $5.26B | 36.2x |
| MMED Minimed Group, Inc. | ▶ | $5.18B | – |
| HTFL Heartflow, Inc. | ▲ | $4.38B | – |
| ICUI Icu Medical Inc/De | ▼ | $4.08B | – |
| IRTC Irhythm Holdings, Inc. | ▼ | $3.55B | – |
| PLSE Pulse Biosciences, Inc. | ▲ | $3.46B | – |
| ATRC Atricure, Inc. | ▶ | $2.89B | – |
| UFPT Ufp Technologies Inc | ▶ | $2.28B | 31.5x |
| INSP Inspire Medical Systems, Inc. | ▶ | $1.99B | 14.7x |
| LMAT Lemaitre Vascular Inc | ▲ | $1.86B | 28.4x |
| ATEC Alphatec Holdings, Inc. | ▲ | $1.67B | – |
| NVCR Novocure Ltd | ▲ | $1.67B | – |
| KMTS Kestra Medical Technologies, Ltd. | ▲ | $1.61B | – |
| DRTS Alpha Tau Medical Ltd. | ▲ | $1.21B | – |
| TNDM Tandem Diabetes Care Inc | ▶ | $1.16B | – |
| IRMD Iradimed Corp | ▲ | $1.15B | 49.7x |
| BVS Bioventus Inc. | ▶ | $1.14B | 20.9x |
| IART Integra Lifesciences Holdings Corp | ▼ | $1.08B | – |
| AORT Artivion, Inc. | ▲ | $1.04B | – |
| SIBN Si-Bone, Inc. | ▲ | $882M | – |
| SGP Spyglass Pharma, Inc. | ▲ | $800M | – |
| BBNX Beta Bionics, Inc. | ▲ | $796M | – |
| MDXG Mimedx Group, Inc. | ▲ | $684M | – |
| KIDS Orthopediatrics Corp | ▶ | $573M | – |
| SSII Ss Innovations International, Inc. | ▲ | $511M | – |
| TCMD Tactile Systems Technology Inc | ▲ | $505M | 20.3x |
| BWAY Brainsway Ltd. | ▲ | $467M | – |
| SGHT Sight Sciences, Inc. | ▲ | $462M | – |
| CERS Cerus Corp | ▲ | $455M | – |
| ANGO Angiodynamics Inc | ▲ | $451M | – |
| NPCE Neuropace Inc | ▶ | $435M | – |
| RCEL Avita Medical, Inc. | ▲ | $413M | – |
| CARL Carlsmed, Inc. | ▲ | $395M | – |
| OFIX Orthofix Medical Inc. | ▼ | $377M | – |
| EMBC Embecta Corp. | ▲ | $351M | 4.0x |
| OBIO Orchestra Biomed Holdings, Inc. | ▲ | $344M | – |
| CLPT Clearpoint Neuro, Inc. | ▲ | $299M | – |
| MOBI Mobia Medical, Inc. | ▲ | $283M | – |
| ANIK Anika Therapeutics, Inc. | ▲ | $275M | – |
| TMCI Treace Medical Concepts, Inc. | ▲ | $267M | – |
| OSUR Orasure Technologies Inc | ▲ | $263M | – |
| PROF Profound Medical Corp. | ▲ | $256M | – |
FAQ
Is Procept Biorobotics Corp a good stock to buy?
Our AI analyzes Procept Biorobotics Corp daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Procept Biorobotics Corp predictions?
A per-ticker accuracy statistic for PRCT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Procept Biorobotics Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Procept Biorobotics Corp? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.